BioSpace News Archive

Press Releases

Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong

October 31, 2025
·
3 min read
Press Releases

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

October 31, 2025
·
8 min read
Press Releases

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025

October 31, 2025
·
7 min read
Press Releases

Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox

October 31, 2025
·
4 min read
Press Releases

Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance

October 31, 2025
·
20 min read
Press Releases

Libtayo® (cemiplimab for injection) Now Reimbursed in Seven Provinces for Advanced Non-Small Cell Lung Cancer and Locally Advanced Basal Cell Carcinoma

October 31, 2025
·
7 min read
Press Releases

Libtayo® (cemiplimab for injection) Now Reimbursed in Québec for Advanced Non-Small Cell Lung Cancer

October 31, 2025
·
6 min read
Press Releases

Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ® 25 and 50 mg

October 31, 2025
·
5 min read
Press Releases

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

October 31, 2025
·
5 min read
Press Releases

Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025

October 31, 2025
·
2 min read